Lightchain Capital

Recent News

CareVet-Logo-New
February 17, 2022

CareVet launches Carebnb

READ MORE
CareVet-Logo-New
February 17, 2022

CareVet Launches Carebnb

READ MORE
Logo-Geneoscopy-400
January 20, 2022

Geneoscopy Tackles Healthcare Disparities in Pivotal Colorectal Cancer Clinical Trial Utilizing a Digital Recruitment Strategy

READ MORE
Logo-Geneoscopy-400
January 20, 2022

Geneoscopy Tackles Healthcare Disparities in Pivotal Colorectal Cancer Clinical Trial Utilizing a Digital Recruitment Strategy

READ MORE
C4-logo-400
January 10, 2022

C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio

READ MORE
C4-logo-400
January 03, 2022

C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

READ MORE
C4-logo-400
December 17, 2021

C4 Therapeutics Added to NASDAQ Biotechnology Index

READ MORE
wugen-logo-400
December 12, 2021

Wugen Presents New Preclinical Data Supporting the Safety and Efficacy of WU-CART-007 for T-Cell Malignancies at the 63rd Annual Society of Hematology (ASH) Annual Meeting

READ MORE
Logo-Geneoscopy-400
November 19, 2021

Geneoscopy Announces Positive Results of Colorectal Cancer Screening Test in Prospective, Multicenter Clinical Study

READ MORE

Contact Us

Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131

 

LinkedIn

Submit

©2024 LIGHTCHAIN CAPITAL, LLC  All Rights Reserved | Privacy Policy
Website by Tidal Media Group